UNSPSC 51292023: Escitalopram oxalate

This classification denotes a selective serotonin reuptake inhibitor and antidepressant agent with the molecular formula C20H21FN2O.C2H2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5U85DBW7LO, chemically known as 5-isobenzofurancarbonitrile, 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydro-, (1s)- but more generally known as escitalopram oxalate, which bears US NIH Compound Identifier 146570.

UNSPSC 51292023 Escitalopram oxalate is a Commodity code for pharmaceutical products, though state and local procurement activity under this specific code shows minimal recent relevant opportunities. The single recent solicitation tagged to this code—Seminole County, Florida's IFB60459723LAS for Naloxone and Safe Drug Deactivation Systems—addresses opioid overdose response and harm reduction, not escitalopram (a selective serotonin reuptake inhibitor antidepressant). The mismatch suggests that either the code was misapplied during the Seminole County procurement posting or that the code does not capture the actual pharmaceutical procurement patterns in state and local markets at present.

Seminole County, Florida posted the naloxone and deactivation systems procurement as an IFB on June 30, 2026, with a response deadline of July 26, 2023—an inconsistent date range that reflects data quality issues in the source record. The solicitation sought 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries, bidders were required to submit electronically through the county's e-Procurement Portal, and the contract included a two-year initial term with an optional one-year renewal. Vendors had to meet E-Verify compliance, maintain workers' compensation and commercial general liability insurance, and comply with federal requirements when FEMA funding applied. Without additional state and local opportunities under this Commodity code in the source, no broader geographic or issuing-body pattern emerges to support market characterization or pursuit recommendations.